Name
Weight
9.70 %
8.60 %
8.38 %
7.07 %
3.35 %
3.08 %
2.91 %
2.60 %
2.17 %
2.11 %
2.00 %
1.90 %
1.54 %
1.47 %
1.45 %
1.40 %
1.30 %
1.24 %
1.22 %
1.12 %
1.11 %
1.10 %
0.99 %
0.95 %
0.94 %
0.92 %
0.84 %
0.81 %
0.79 %
0.70 %
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Technical Analysis
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend per share
Dividend yield
Name
Weight
9.70 %
8.60 %
8.38 %
7.07 %
3.35 %
3.08 %
2.91 %
2.60 %
2.17 %
2.11 %
2.00 %
1.90 %
1.54 %
1.47 %
1.45 %
1.40 %
1.30 %
1.24 %
1.22 %
1.12 %
1.11 %
1.10 %
0.99 %
0.95 %
0.94 %
0.92 %
0.84 %
0.81 %
0.79 %
0.70 %
Analyst ratings
FAQ
- What is IBB?
- Does IBB pay dividends?
- What stocks are in IBB?
- What is the current assets under management for IBB?
- What is IBB average volume?
- What is IBB expense ratio?
- What is IBB inception date?
What is IBB?
The IBB ETF, or iShares Nasdaq Biotechnology ETF, focuses on biotechnology companies. It aims to track the performance of the Nasdaq Biotechnology Index, providing investors exposure to the biotech sector, including drug development and research firms. It's popular for those seeking growth in healthcare innovation.
Does IBB pay dividends?
Yes, the iShares Biotechnology ETF does pays dividends, with
the most recent payment being
$0.06
per share. The last ex-dividend date was on December 17, 2024, and the next ex-dividend date has not been announced yet
What stocks are in IBB?
As of today, iShares Biotechnology ETF inlcudes 259 holdings, with 254 of them being companies from 15 different countries and 1 sectors. The most weighted holdings are Gilead Sciences (9.7%), Amgen (8.6%) and Vertex Pharmaceuticals Incorporated (8.38%)
What is the current assets under management for IBB?
Assets under management of iShares Biotechnology ETF is $6 B
What is IBB average volume?
Average volume of iShares Biotechnology ETF is $1 M
What is IBB expense ratio?
Expense ratio of iShares Biotechnology ETF is 0.45%
What is IBB inception date?
Inception date of iShares Biotechnology ETF is February 12, 2001